Skip to main content

Table 1 Baseline characteristics of patients with pulmonary sclerosing pneumocytoma

From: Pulmonary sclerosing pneumocytoma and mortality risk

Baseline characteristics

PSP surgery group

(N = 80)

PSP non-surgery group

(N = 27)

Total

(N = 107)

P

Age, years

50.9 ± 12.7

49.8 ± 11.9

50.6 ± 12.5

0.684

Female

72 (90.0)

26 (96.3)

98 (91.6)

0.444

Body mass index, kg/m2

22.5 ± 3.2

24.0 ± 3.4

23.0 ± 3.2

0.358

Never Smoker

71 (88.8)

22 (81.5)

93 (86.9)

0.337

Comorbidities

Hypertension

1 (1.2)

1 (3.7)

2 (1.9)

0.443

Diabetes

0 (0.0)

1 (3.7)

1 (0.9)

0.252

Dyslipidemia

2 (2.5)

0 (0.0)

2 (1.9)

1.000

Respiratory diseases

1 (1.2)

0 (0.0)

1 (0.9)

1.000

Cardiovascular diseases

5 (6.2)

0 (0.0)

5 (4.7)

0.327

Chronic liver diseases

1 (1.2)

0 (0.0)

1 (0.9)

1.000

Chronic kidney diseases

0 (0.0)

0 (0.0)

0 (0.0)

1.000

Malignancy

21 (26.2)

8 (29.6)

29 (27.1)

0.927

  1. Continuous variables are expressed as mean ± standard deviation
  2. Categorical variables are expressed as number (%)